CARD17 Antikörper (Middle Region)

Produktnummer ABIN926695

Produktdetails anti-CARD17 Antikörper

Target: CARD17 (Caspase Recruitment Domain Family, Member 17 (CARD17))

Bindungsspezifität: Middle Region

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CARD17 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: Purified

Immunogen: CARD17 antibody was raised in rabbit using the middle region of CARD17 as the immunogen

Anwendungsinformationen

Applikationshinweise: Optimal conditions should be determined by the investigator.

Kommentare:

CARD17 Blocking Peptide, catalog no. 33R-5841, is also available for use as a blocking control in assays to test for specificity of this CARD17 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu CARD17

Target: CARD17 (Caspase Recruitment Domain Family, Member 17 (CARD17))

Andere Bezeichnung: CARD17 (CARD17 Produkte)

Synonyme: INCA antikoerper, caspase recruitment domain family member 17 antikoerper, CARD17 antikoerper

Hintergrund: As a regulator of procaspase-1/CASP1 activation, CARD17 is implicated in the regulation of the proteolytic maturation of pro-IL-1beta/IL1B and its release during inflammation. CARD17 inhibits the release of IL1B in response to LPS in monocytes. However, unlike CASP1, CARD17 do not induce NF-kappa-B activation. Synonyms: Polyclonal CARD17 antibody, Anti-CARD17 antibody, caspase recruitment domain family, member 17 antibody, INCA antibody.